; (2) includes an up-to-date summary of complete, underway, and planned data collection and analysis related to chronic pain that is conducted and supported by the Centers for Disease Control and Prevention; and (3) translates research findings into clinical tools and resources, recommendations for closing research gaps, and recommendations for population research standards for researchers, with recommendations updated annually to incorporate research findings from the prior year. (c) Conflicts of interest If an individual or organization that collaborates with the Secretary in carrying out subsection (a) receives a payment or other transfer of value of a type described in section 1128G(a)(1)(A)(vi) of the Social Security Act from a manufacturer of a drug (including a biological product) or device that would be required to be disclosed pursuant to section 1128G(a)(1) of the Social Security Act, if the individual or organization were a covered recipient or if such disclosure were required upon request of or by designation on behalf of a covered recipient pursuant to such section, the individual or organization shall disclose to the Secretary information regarding such payment or other transfer of value. The Secretary shall make such disclosures publicly available. (d) Report Not later than 2 years after the date of the enactment of the Advancing Research for Chronic Pain Act of 2024 , the Secretary shall submit a report to Congress concerning the implementation of this section. Such report shall include information on— (1) the development and maintenance of the Chronic Pain Information Hub; (2) the information made available through the Chronic Pain Information Hub; (3) the data gaps identified, and planned efforts to address such gaps; (4) the process established for soliciting feedback from collaborators